期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Large Cohort Data Based Cost-Effective Disease Prevention Design Strategy: Strong Heart Study
1
作者 Wenyu Wang Elisa T. Lee +3 位作者 barbara v. howard Richard Devereux Ying Zhang Julie A. Stoner 《World Journal of Cardiovascular Diseases》 2018年第12期588-601,共14页
Background and Objective: A multitude of large cohort studies have collected data on incidence and covariates/risk factors of various chronic diseases. However, approaches for utilization of these large data and trans... Background and Objective: A multitude of large cohort studies have collected data on incidence and covariates/risk factors of various chronic diseases. However, approaches for utilization of these large data and translation of the valuable results to inform and guide clinical disease prevention practice are not well developed. In this paper, we proposed, based on large cohort study data, a novel conceptual cost-effective disease prevention design strategy for a target group when it is not affordable to include everyone in the target group for intervention. Methods and Results: Data from American Indian participants (n = 3516;2056 women) aged 45 - 74 years in the Strong Heart Study, the diabetes risk prediction model from the study, a utility function, and regression models were used. A conceptual cost-effective disease prevention design strategy based on large cohort data was initiated. The application of the proposed strategy for diabetes prevention was illustrated. Discussion: The strategy may provide reasonable solutions to address cost-effective prevention design issues. These issues include complex associations of a disease with its significant risk factors, cost-effectively selecting individuals at high risk of developing disease to undergo intervention, individual differences in health conditions, choosing intervention risk factors and setting their appropriate, attainable, gradual and adaptive goal levels for different subgroups, and assessing effectiveness of the prevention program. Conclusions: The strategy and methods shown in the illustrative example can also be analogously adopted and applied to other diseases preventions. The proposed strategy provides a way to translate and apply epidemiological study results to clinical disease prevention practice. 展开更多
关键词 COST-EFFECTIVE Costs-Benefits-Balanced Selecting Disease PREVENTION PREVENTION Design PREVENTION Strategy TRANSLATE STUDY to Clinical Practice
下载PDF
Large Cohort Data Based Group or Community Disease Prevention Design Strategy: Strong Heart Study
2
作者 Wenyu Wang Elisa T. Lee +3 位作者 barbara v. howard Richard Devereux Ying Zhang Julie A. Stoner 《World Journal of Cardiovascular Diseases》 2018年第3期196-207,共12页
Background and Objective: A multitude of large cohort studies have data on incidence rates and predictors of various chronic diseases. However, approaches for utilization of these costly collected data and translation... Background and Objective: A multitude of large cohort studies have data on incidence rates and predictors of various chronic diseases. However, approaches for utilization of these costly collected data and translation of these?valuable results to inform and guide clinical disease prevention practice are?not well developed. In this paper we proposed a novel conceptual group/community disease prevention design strategy based on large cohort study data. Methods and Results: The data from participants (n = 3516;2056 women) aged 45 to 74 years and the diabetes risk prediction model from Strong Heart Study were used. The Strong Heart Study is a population-based cohort study of cardiovascular disease and its risk factors in American Indians. A conceptual group/community disease prevention design strategy based on large cohort data was initiated. The application of the proposed strategy for group diabetes prevention was illustrated. Discussion: The strategy may provide reasonable solutions to the prevention design issues. These issues include complex associations of a disease with its combined and correlated risk factors, individual differences, choosing intervention risk factors and setting their appropriate, attainable, gradual and adaptive goal levels for different subgroups, and assessing effectiveness of the prevention program. Conclusions: The strategy and methods shown in the illustration example can be analogously adopted and applied for other diseases preventions. The proposed strategy for a target group/community in a population provides a way to translate and apply epidemiological study results to clinical disease prevention practice. 展开更多
关键词 Group/Community Disease PREVENTION PREVENTION Design PREVENTION Strategy TRANSLATE STUDY to Clinical Practice
下载PDF
Risk Factors and Prediction of Stroke in a Population with High Prevalence of Diabetes: The Strong Heart Study
3
作者 Wenyu Wang Ying Zhang +13 位作者 Elisa T. Lee barbara v. howard Richard B. Devereux Shelley A. Cole Lyle G. Best Thomas K. Welty Everett Rhoades Jeunliang Yeh Tauqeer Ali Jorge R. Kizer Hooman Kamel Nawar Shara David O. Wiebers Julie A. Stoner 《World Journal of Cardiovascular Diseases》 2017年第5期145-162,共18页
Background and Objective: American Indians have a high prevalence of diabetes and higher incidence of stroke than that of whites and blacks in the U.S. Stroke risk prediction models based on data from American Indians... Background and Objective: American Indians have a high prevalence of diabetes and higher incidence of stroke than that of whites and blacks in the U.S. Stroke risk prediction models based on data from American Indians would be of clinical and public health value. Methods and Results: A total of 3483 (2043 women) Strong Heart Study participants free of stroke at baseline were followed from 1989 to 2010 for incident stroke. Overall, 297 stroke cases (179 women) were identified. Cox models with stroke-free time and risk factors recorded at baseline were used to develop stroke risk prediction models. Assessment of the developed stroke risk prediction models regarding discrimination and calibration was performed by an analogous C-statistic (C) and a version of the Hosmer-Lemeshow statistic (HL), respectively, and validated internally through use of Bootstrapping methods. Results: Age, smoking status, alcohol consumption, waist circumference, hypertension status, antihypertensive therapy, fasting plasma glucose, diabetes medications, high/low density lipoproteins, urinary albumin/creatinine ratio, history of coronary heart disease/heart failure, atrial fibrillation, or Left ventricular hypertrophy, and parental history of stroke were identified as the significant optimal risk factors for incident stroke. Discussion: The models produced a C = 0.761 and HL = 4.668 (p = 0.792) for women, and a C = 0.765 and HL = 9.171 (p = 0.328) for men, showing good discrimination and calibration. Conclusions: Our stroke risk prediction models provide a mechanism for stroke risk assessment designed for American Indians. The models may be also useful to other populations with high prevalence of obesity and/or diabetes for screening individuals for risk of incident stroke and designing prevention programs. 展开更多
关键词 STROKE Risk Factors PREDICTION Prevention
下载PDF
糖耐量受损转化为正常糖耐量或演变为糖尿病者血压均下降——来自大庆糖尿病研究的新发现 被引量:1
4
作者 王瑶 王金平 +8 位作者 李光伟 杨文英 姜亚云 邢小燕 张景玲 萧建忠 胡英华 barbara v. howard Peter H. Bennett 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2008年第3期268-271,共4页
目的分析大庆糖尿病预防研究中糖耐量受损(IGT)人群随访6年期间的糖耐量演变及其与血压变化的关联。方法大庆糖尿病预防研究中有334例IGT患者未曾服用任何降血压药物,其中264例基线血压≥130/80mmHg(1mmHg=0.133kPa)。随机分配... 目的分析大庆糖尿病预防研究中糖耐量受损(IGT)人群随访6年期间的糖耐量演变及其与血压变化的关联。方法大庆糖尿病预防研究中有334例IGT患者未曾服用任何降血压药物,其中264例基线血压≥130/80mmHg(1mmHg=0.133kPa)。随机分配在对照、饮食、运动及饮食加运动干预4个组,从1986年随访到1992年。根据研究结束时口服葡萄糖耐量试验(OGTT)2h血糖水平(2hPG)分为〈7.8、7.8~8.8、8.9~9.9、10.0~11.0、11.1~13.8、13.9~16.6和≥16.7mmol/L7个亚组,探讨各组血压水平的变化及其与血糖变化的关联。结果经多因素分析调整了年龄、性别、基线体重指数及随访期体重变化等因素的影响后,1986至1992年间各组的收缩压改变分别为-2.4、0.6、7.7、4.3、1.7、-2.9、和-6.9mmHg,舒张压变化为-3.2、3.0、3.3、1.7、-0.7、-1.3和-3.7mmHg。收缩压和舒张压在演变为糖耐量正常或糖尿病者比那些仍然保持为IGT且2hPG在8.9~9.9mmol/L者显著下降(均P〈0.05)。264例基线血压≥130/80mmHg者中血压变化更为显著。在上述各组,收缩压变化分别为-5.2、-2.6、5.2、2.3、-2.3、-4.2、-7.6mmHg,舒张压变化分别为-5.0、-3.7、1.5、-2.9、-4.3、-4.0和-6.0mmHg。结论大庆6年研究中IGT人群中血糖水平仍保持为IGT者血压有所升高。相反,IGT转化为正常糖耐量或糖尿病组血压明显下降。 展开更多
关键词 糖耐量受损 糖尿病 血压
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部